Scholars@Duke
Emily Devereux Niehaus

Emily Devereux Niehaus

Assistant Professor of Medicine
Medicine, Infectious Diseases
emily.niehaus@duke.edu
315 Trent Drive, HH Room 145, Durham, NC 27703
315 Trent Drive, HH Room 145, Durham, NC 27703

Selected Publications

Disparities in Mpox Vaccination Among Priority Populations During the 2022 Outbreak.

Journal Article Open Forum Infect Dis · September 2023 BACKGROUND: The 2022 mpox outbreak disproportionately affected men who have sex with men and persons living with HIV (PLWH). A 2-dose mpox vaccine series was deployed in mid-2022. Structural racism and insurance status may have affected equitable vaccinati ... Full text Link to item Cite

Concurrent Sexually Transmitted Infection Testing Among Patients Tested for Mpox at a Tertiary Healthcare System.

Journal Article Open Forum Infect Dis · August 2023 Coinfection with sexually transmitted infections (STIs) and mpox is common. We evaluated concurrent STI testing among Duke Health patients tested for mpox. We found that most patients tested for mpox were not comprehensively tested for STIs, despite concur ... Full text Link to item Cite

Disparity in Quality of Infectious Disease vs Addiction Care Among Patients With Injection Drug Use-Associated Staphylococcus aureus Bacteremia.

Journal Article Open Forum Infect Dis · July 2019 Evidence-based interventions for Staphylococcus aureus bacteremia (SAB) are well known, but it is unclear how they are implemented among patients with injection drug use-associated (IDU) SAB. Of 46 patients with IDU-SAB identified, all received high-qualit ... Full text Link to item Cite

Repletion of Iron Stores With the Use of Oral Iron Supplementation in Patients With Systolic Heart Failure.

Journal Article J Card Fail · August 2015 BACKGROUND: Iron deficiency is associated with reduced functional capacity and increased mortality in patients with heart failure with reduced ejection fraction (HFrEF). Correction of iron deficiency in HFrEF patients with the use of intravenous iron impro ... Full text Link to item Cite

Predictors of survival to orthotopic heart transplant in patients with light chain amyloidosis.

Journal Article J Heart Lung Transplant · February 2014 BACKGROUND: Orthotopic heart transplant (OHT), followed by myeloablative chemotherapy and autologous stem cell transplant (ASCT), has been successful in the treatment of amyloid light-chain (AL) cardiac amyloidosis. The purpose of this study was to identif ... Full text Link to item Cite